Although ultrasound dilution (UD) monitoring of AV access flow is widely used in adult HD units for early stenosis detection, its experience in pediatric units is limited. Therefore, a group at Boston Children’s Hospital conducted a study to evaluate the impact of UD monitoring on AV access-related morbidity, especially access thrombosis.
Secondary morbidity outcomes were also evaluated, including access-related hospitalizations and need for new access creation or temporary dialysis catheter placement.
Researchers evaluated UD monitoring to screen for hemodynamically significant AV stenosis by:
- Differentiating between patent AV accesses and those at true risk to thrombose.
- Detecting improvements in blood flow to restore patency after interventional procedures.
- Determining UD’s sensitivity and specificity for detecting stenoses vis á vis fistulagrams.
They found that:
- AV access thrombosis rates fell from 13.5 per 100 patient-months on HD during the baseline period to 3.5 per 100 patient-months on HD during the screening period (p < 0.04).
- Secondary complications (hospitalizations, new access creation, temporary dialysis catheter placement) declined from 4 events per 100 patient-months during baseline period and to 2.5 events per 100 patient-months during surveillance period.
- Mean blood flow rate by UD measurement was lower in AV accesses that went on to thrombose compared with those without thrombosis (1,203 ml/min/1.73 m2 vs. 1,683 ml/min/1.73 m2, p < 0.001).
- Following angioplasty, median flow rate increased from 730 ml/min to 1,180 ml/min.
- When compared to fistulagrams, UD surveillance was 94% sensitive and 77% specific in detecting hemodynamically significant stenosis, with positive and negative predictive values of 83% and 91% respectively.
The group concluded that UD screening is sensitive in detecting hemodynamically significant stenosis and can decrease AV access thrombosis rates in children.
Reference:
Ashoor IF, Hughson EA, Somers MJ, “Arteriovenous access monitoring with ultrasound dilution in a pediatric hemodialysis unit.” Blood Purif. 2015;39(1-3):93-8. (Transonic Reference: HD10296AH)